Volume 16 - Issue 9 - September 2008
09/22/2008
Said to be flexible and precise, the MOSAIC fractional laser system from Lutronic USA (Princeton Junction, NJ) is designed for a variety of aesthetic and dermatological applications, including scarring, sun-damaged skin and skin...
Said to be flexible and precise, the MOSAIC fractional laser system from Lutronic USA (Princeton Junction, NJ) is designed for a variety of aesthetic and dermatological applications, including scarring, sun-damaged skin and skin...
Said to be flexible and precise,...
09/22/2008
The Dermatologist
09/22/2008
According to information provided by the Melanoma Research Foundation (MRF), the health benefits of vitamin D — which can be gotten safely from diet and supplements — through sunlight exposure are greatly outweighed by the risks associated...
According to information provided by the Melanoma Research Foundation (MRF), the health benefits of vitamin D — which can be gotten safely from diet and supplements — through sunlight exposure are greatly outweighed by the risks associated...
According to information...
09/22/2008
The Dermatologist
09/22/2008
Dermal Optical Thermolysis (DOT) — CO2 technology that ablates a customized pattern of dots instead of the entire skin surface — has entered the U.S. market via an alliance between the U.S. laser distributor Eclipse, and DEKA, its Italian...
Dermal Optical Thermolysis (DOT) — CO2 technology that ablates a customized pattern of dots instead of the entire skin surface — has entered the U.S. market via an alliance between the U.S. laser distributor Eclipse, and DEKA, its Italian...
Dermal Optical Thermolysis (DOT)...
09/22/2008
The Dermatologist
News
09/22/2008
Renovo’s Phase II trial for Juvista in scar revision surgery has met its primary endpoint. The randomized, double-blind, placebo-controlled study investigated the safety and efficacy of Juvista given at the time of surgery following wound...
Renovo’s Phase II trial for Juvista in scar revision surgery has met its primary endpoint. The randomized, double-blind, placebo-controlled study investigated the safety and efficacy of Juvista given at the time of surgery following wound...
Renovo’s Phase II trial for...
09/22/2008
The Dermatologist
09/22/2008
Two studies presented as posters at the American Society for Laser Medicine and Surgery (ASLMS) meeting support the safety and efficacy claims of Cutera, Inc. (Brisbane, CA) for its 2,790 nm Pearl YSGG Laser.
Assessment of the Impact of...
Two studies presented as posters at the American Society for Laser Medicine and Surgery (ASLMS) meeting support the safety and efficacy claims of Cutera, Inc. (Brisbane, CA) for its 2,790 nm Pearl YSGG Laser.
Assessment of the Impact of...
Two studies presented as posters...
09/22/2008
The Dermatologist
News
09/22/2008
LEO Pharma’s new drug for treatment of scalp psoriasis, Xamiol, has been approved in 16 European countries. The UK will be the first country to market Xamiol. In extensive clinical studies, Xamiol has proved to be a very efficient drug in the...
LEO Pharma’s new drug for treatment of scalp psoriasis, Xamiol, has been approved in 16 European countries. The UK will be the first country to market Xamiol. In extensive clinical studies, Xamiol has proved to be a very efficient drug in the...
LEO Pharma’s new drug for...
09/22/2008
The Dermatologist
09/22/2008
FDA-approved for pain reduction during laser or light-based aesthetic treatments, the Serenity Pro from Candela Corporation (Wayland, MA) uses a proprietary and patented technology called Pneumatic Skin Flattening (PSF) to reduce pain during...
FDA-approved for pain reduction during laser or light-based aesthetic treatments, the Serenity Pro from Candela Corporation (Wayland, MA) uses a proprietary and patented technology called Pneumatic Skin Flattening (PSF) to reduce pain during...
FDA-approved for pain reduction...
09/22/2008
The Dermatologist
News
09/22/2008
Galderma recently announced that Japan’s Ministry of Health, Labor and Welfare has approved adapalene (Differin Gel 0.1%), a novel topical treatment for acne vulgaris. The drug will be marketed in Japan by Galderma KK, the fully-owned...
Galderma recently announced that Japan’s Ministry of Health, Labor and Welfare has approved adapalene (Differin Gel 0.1%), a novel topical treatment for acne vulgaris. The drug will be marketed in Japan by Galderma KK, the fully-owned...
Galderma recently announced that...
09/22/2008
The Dermatologist
09/22/2008
The TRIA Personal Laser Hair Removal System, the first FDA-cleared laser for at-home hair removal in the United States, can now be purchased from designated aesthetic physicians nationwide, with additional distribution in fall 2008 at select...
The TRIA Personal Laser Hair Removal System, the first FDA-cleared laser for at-home hair removal in the United States, can now be purchased from designated aesthetic physicians nationwide, with additional distribution in fall 2008 at select...
The TRIA Personal Laser Hair...
09/22/2008
The Dermatologist
News
09/22/2008
The FDA approved Aurobindo Pharma’s generic version of the injectable antibiotic cefazolin made by Abraxis Pharmaceutical. Cefazolin, a cephalosporin antibiotic, is used to eliminate bacteria that cause different types of infections,...
The FDA approved Aurobindo Pharma’s generic version of the injectable antibiotic cefazolin made by Abraxis Pharmaceutical. Cefazolin, a cephalosporin antibiotic, is used to eliminate bacteria that cause different types of infections,...
The FDA approved Aurobindo...
09/22/2008
The Dermatologist
